ES2195571T3 - Nuevos benzonaftiridin-n-oxidos. - Google Patents

Nuevos benzonaftiridin-n-oxidos.

Info

Publication number
ES2195571T3
ES2195571T3 ES99922133T ES99922133T ES2195571T3 ES 2195571 T3 ES2195571 T3 ES 2195571T3 ES 99922133 T ES99922133 T ES 99922133T ES 99922133 T ES99922133 T ES 99922133T ES 2195571 T3 ES2195571 T3 ES 2195571T3
Authority
ES
Spain
Prior art keywords
alkoxy
hydroxy
cycloalkylmethoxy
cycloalkoxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99922133T
Other languages
English (en)
Spanish (es)
Inventor
Beate Gutterer
Hermann Amschler
Wolf-Rudiger Ulrich
Thomas Martin
Thomas Bar
Armin Hatzelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of ES2195571T3 publication Critical patent/ES2195571T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
ES99922133T 1998-05-05 1999-04-27 Nuevos benzonaftiridin-n-oxidos. Expired - Lifetime ES2195571T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98108124 1998-05-05

Publications (1)

Publication Number Publication Date
ES2195571T3 true ES2195571T3 (es) 2003-12-01

Family

ID=8231880

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99922133T Expired - Lifetime ES2195571T3 (es) 1998-05-05 1999-04-27 Nuevos benzonaftiridin-n-oxidos.

Country Status (12)

Country Link
US (1) US6306869B1 (enExample)
EP (1) EP1075477B1 (enExample)
JP (1) JP2002513793A (enExample)
AT (1) ATE234301T1 (enExample)
AU (1) AU3928999A (enExample)
CA (1) CA2330738A1 (enExample)
DE (1) DE59904535D1 (enExample)
DK (1) DK1075477T3 (enExample)
ES (1) ES2195571T3 (enExample)
PT (1) PT1075477E (enExample)
SI (1) SI1075477T1 (enExample)
WO (1) WO1999057118A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5970199A (en) 1998-08-31 2000-03-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
SI1212089T1 (sl) * 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
DE60133879D1 (de) 2000-01-11 2008-06-19 Nycomed Gmbh Phenanthridin -n- oxide
SI1377574T1 (enExample) * 2001-02-21 2005-08-31 Altana Pharma Ag
PL373598A1 (en) * 2002-08-17 2005-09-05 Altana Pharma Ag Novel benzonaphthyridines
AU2003255493B8 (en) * 2002-08-29 2009-03-26 Takeda Gmbh 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
JP4587295B2 (ja) * 2002-08-29 2010-11-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Pde4インヒビターとしての3−ヒドロキシ−6−フェニルフェナントリジン
DE60313331T2 (de) * 2002-09-04 2008-01-03 Nycomed Gmbh Neue benzonaphthyridine
US7470704B2 (en) 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
IS7839A (is) * 2002-11-22 2004-05-23 Merck Frosst Canada Ltd. 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
AU2005212857B2 (en) * 2004-02-18 2011-04-28 Takeda Gmbh Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
SI2589599T1 (sl) 2004-03-03 2014-10-30 Takeda Gmbh Novi hidroksi-6-heteroarilfenantridini in njihova uporaba kot PDE4 inhibitorji
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
WO2005084104A2 (en) * 2004-03-09 2005-09-15 Altana Pharma Ag Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
JP2007527900A (ja) * 2004-03-10 2007-10-04 アルタナ ファルマ アクチエンゲゼルシャフト チオ含有の新規のヒドロキシ−6−フェニルフェナントリジン及びpde4インヒビターとしてのそれらの使用
AU2005219581A1 (en) * 2004-03-10 2005-09-15 Nycomed Gmbh Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
AU2005221832A1 (en) * 2004-03-10 2005-09-22 Nycomed Gmbh Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
AU2005223386A1 (en) 2004-03-17 2005-09-29 Nycomed Gmbh Novel N- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE3/4 inhibitors
EP1791847A2 (en) 2004-09-08 2007-06-06 Altana Pharma AG Novel 3-thia-10-aza-phenanthrene derivatives
ES2365926T3 (es) * 2004-09-08 2011-10-13 Nycomed Gmbh 3-oxa-10-aza-fenantrenos como inhibidores de pde4 o pde3/4.
NZ560268A (en) 2005-03-02 2010-12-24 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
NZ334976A (en) 1996-11-11 2000-10-27 Byk Gulden Lomberg Chem Fab Benzonaphthyridine derivatives and their use for treating airway disorders and dermatoses

Also Published As

Publication number Publication date
PT1075477E (pt) 2003-07-31
JP2002513793A (ja) 2002-05-14
EP1075477A1 (de) 2001-02-14
AU3928999A (en) 1999-11-23
US6306869B1 (en) 2001-10-23
DK1075477T3 (da) 2003-06-30
EP1075477B1 (de) 2003-03-12
CA2330738A1 (en) 1999-11-11
SI1075477T1 (en) 2003-08-31
ATE234301T1 (de) 2003-03-15
DE59904535D1 (de) 2003-04-17
WO1999057118A1 (de) 1999-11-11

Similar Documents

Publication Publication Date Title
ES2195571T3 (es) Nuevos benzonaftiridin-n-oxidos.
ES2171040T3 (es) Derivados de esteres hidroxiaceticos y su utilizacion como intermediarios de sintesis.
AR043436A1 (es) Tetrahidroisoquinolinas sustituidas para uso como moduladores 5-ht6
ECSP099395A (es) Nuevos derivados de los ácidos amino-nicotínico y amino-isonicotínico
ECSP055636A (es) Acidos tienil-hidroxamicos sustituidos, y su uso para tratar enfermedades asociadas con la actividad enzimatica de la histona desacetilasa
ECSP045369A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica
PA8609201A1 (es) Piridinonas sustituidas
YU48390B (sh) Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
NO953305L (no) Antranilsyrederivat
ES2188584T3 (es) Derivados heterociclicos de amina.
ES2132373T3 (es) Benzocicloheptenos, benzoxepinas y benzotiepinas.
AR026351A1 (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
ECSP045420A (es) Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen
DE69925472D1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
ES2106185T3 (es) 3-carboxiesteroides 17-beta-sustituidos no saturados.
AR005034A1 (es) Derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos
ES2177275T3 (es) Derivados de oxadiazolina y su uso como insecticidas.
BRPI0511581A (pt) derivados de tetrahidroisoquinolilsulfonamidas, sua preparação e sua utilização em terapêutica
CO5680420A2 (es) Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4
DK1450750T3 (da) Derivater af 2-amoni-4-pyridiylmethylthiazolin og anvendelse deraf som inhibitorer af inducerbar NO-syntase
CO4930268A1 (es) BENZO[e]ISOINDOLES Y BENZO[h]ISOQUINOLINAS TRICICLICOS